Views & Analysis | Perspectives on pharma industry issues

Oncology

pharmaphorum podcast Episode 282 at ESMO26: Dr Chuck Link, Syncromune

ESMO26: Lowering toxicity, extending lives, with Syncromune

As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.

Oncology

Why precision biomarkers will change the future of breast ca...

Blood-based biomarkers can provide an earlier, dynamic view of what is happening inside a patient, creating an opportunity to detect changes sooner.

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Market Access

Sponsored

The pre-commercial case for connecting data before acquiring...

For EBPs, launch requires a data strategy that starts with agreement on the KPIs, and those depend on the therapeutic areas.

Articles

FDA post-election: continuity and progress likely to mark 20...

Regulatory expert Steven Grossman shares his views on the recent US Presidential election and how this decision will affect the FDA and the healthcare industry this year. Looking back over the last 40 years at FDA (as I have), there are three characteristics that create a more...

Articles

The two schools of digital marketing

Morten Hjelmsø of agnitio explores the role of technology within pharmaceutical marketing. This is a turning point for pharmaceutical marketing. Right now, technology is being implemented that will shape how...

Articles

Innovation in the pharma industry (part 4): how do you see d...

In the final part of our video series on innovation in pharma, several attendees of Cegedim Relationship Management’s life science event share their thoughts on how they see delivery of innovation changing for pharma in the future. Previously in this series, we have looked at how well pharma is currently driving innovation, what challenges there are to implementing it and what can help...

Sales & Marketing

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital